Trial site
Fukuoka University Chikushi Hospital
- 17running trials
- 8closed trials
The trials here
What the 25 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis12 trials
- Crohn's disease9 trials
- Chronic kidney disease1 trial
- COPD1 trial
- Fabry disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- High blood pressure1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 314 trials
- Phase 25 trials
- Phase 2/33 trials
- Status
- Active, not recruiting13 trials
- Completed7 trials
- Recruiting3 trials
- Not yet recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- Janssen Research & Development, LLC5 trials
- Abivax S.A.2 trials
- Hoffmann-La Roche2 trials
- Takeda2 trials
- and 9 more
Running trials
Recruiting
Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis
Recruiting
Recruiting
Active, not recruiting
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease2 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Recruiting
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Completed
Completed
Completed
Completed
Completed
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026